An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Here, Hanke et al. immunize an alpaca with SARS-CoV-2 spike protein domains and identify a nanobody that binds the receptor binding domain of spike in both the up and down conformations and sterically hinders ACE2 engagement.
Enregistré dans:
Auteurs principaux: | Leo Hanke, Laura Vidakovics Perez, Daniel J. Sheward, Hrishikesh Das, Tim Schulte, Ainhoa Moliner-Morro, Martin Corcoran, Adnane Achour, Gunilla B. Karlsson Hedestam, B. Martin Hällberg, Ben Murrell, Gerald M. McInerney |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5d6d86e0a27242f592c4fcf292d06534 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
par: Tânia F. Custódio, et autres
Publié: (2020) -
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
par: Daniel J. Sheward, et autres
Publié: (2021) -
Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity
par: Martin M. Corcoran, et autres
Publié: (2016) -
Evaluation of antidiphtheria toxin nanobodies
par: Ghada H Shaker
Publié: (2010) -
Farmacocinética de la ampicilina en Alpacas (Lama pacos )
par: KREIL,V, et autres
Publié: (2001)